| 論文 |
papers |
-
Potential link between COVID-19 infection/vaccination and the onsets of TAFRO syndrome and idiopathic multicentric castleman disease. Masataka Umeda,Lamiaa Mohamed,Ayaka Umetsu,Mizuna Otsuka,Yushiro Endo,Toshimasa Shimizu,Shoichi Fukui,Remi Sumiyoshi,Tomohiro Koga,Atsushi Kawakami Immunology letters 278巻107123頁-107123頁 2026年04月
-
Visualizing malignant progression: in situ CD109-based spatial immunofluorescence assay delineates papillary to anaplastic thyroid carcinoma transformation within the tumor microenvironment. Tomoko Cohen,Keiji Suzuki,Katsuya Matsuda,Hirokazu Kurohama,Yuki Matsuoka,Mayu Ueda,Shinya Satoh,Hisakazu Shindo,Hiroyuki Yamashita,Atsushi Kawakami,Masahiro Nakashima Scientific reports 2026年02月26日
-
Cytokine/chemokine profiles in rheumatoid arthritis patients who failed Boolean remission solely due to elevated patient global assessment. Shoichi Fukui,Tohru Michitsuji,Yushiro Endo,Ayako Nishino,Kaori Furukawa,Toshimasa Shimizu,Masataka Umeda,Remi Sumiyoshi,Tomohiro Koga,Naoki Iwamoto,Mami Tamai,Tomoki Origuchi,K A van Schie,Yukitaka Ueki,Nobutaka Eiraku,Tamami Yoshitama,Naoki Matsuoka,Takahisa Suzuki,Akitomo Okada,Hiroaki Hamada,Masahiro Ayano,Toshihiko Hidaka,Tomomi Tsuru,Tom W J Huizinga,René E M Toes,Atsushi Kawakami,Shin-Ya Kawashiri Rheumatology (Oxford, England) 65巻2号 2026年02月04日
-
A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoids. Remi Sumiyoshi,Tomohiro Koga,Osamu Kamisawa,Shimpei Morimoto,Naoki Hosogaya,Hiroshi Yamamoto,Makoto Hori,Yosuke Inaba,Yoko Hattori,Tamiki Hikake,Tomoya Kurokawa,Hideki Hanaoka,Shuzo Sato,Kiyoshi Migita,Noriyoshi Ogawa,Motomu Hashimoto,Atsushi Kawakami Drug discoveries & therapeutics 19巻6号404頁-413頁 2026年01月07日
-
Efficacy and safety of efgartigimod PH20 SC for Sjögren’s disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study) Yushiro Endo,Naoki Hosogaya,Yuri Fukushige,Sawana Narita,Julie Jacobs,William Reiss,Yuya Imai,Toshimasa Shimizu,Tomohiro Koga,Hiroshi Yamamoto,Tomoya Sakai,Yukinori Takagi,Misa Sumi,Atsushi Kawakami Frontiers in Medicine 12巻 2026年01月02日
-
Polychondritis and Arthritis in a Patient with Coexisting Alkaptonuria and Psoriasis Vulgaris. Kensei Shono,Eiko Kawakami,Serina Koto,Shoichi Fukui,Takashi Jubashi,Kanako Kojima,Toshimasa Shimizu,Hirofumi Koike,Nozomi Ueki,Atsushi Kawakami Internal medicine (Tokyo, Japan) 2025年12月11日
-
Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer. Yomi Nakashima,Ichiro Horie,Haruka Arimori,Mayu Ueda,Shinpei Nishikido,Yuta Nakamura,Keita Nakaji,Tetsuro Niri,Ayaka Sako,Ai Haraguchi,Toshiyuki Ikeoka,Satoru Akazawa,Akie Moriuchi,Misa Imaizumi,Toshiro Usa,Atsushi Kawakami Endocrine journal 72巻12号1327頁-1337頁 2025年12月01日
-
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis Shoichi Fukui,Tohru Michitsuji,Yushiro Endo,Ayako Nishino,Kaori Furukawa,Toshimasa Shimizu,Masataka Umeda,Remi Sumiyoshi,Tomohiro Koga,Naoki Iwamoto,Mami Tamai,Tomoki Origuchi,K.A. van Schie,Yukitaka Ueki,Nobutaka Eiraku,Tamami Yoshitama,Naoki Matsuoka,Takahisa Suzuki,Akitomo Okada,Hiroaki Hamada,Masahiro Ayano,Toshihiko Hidaka,Tomomi Tsuru,Tom W.J. Huizinga,René E.M. Toes,Atsushi Kawakami,Shin-ya Kawashiri Journal of Autoimmunity 157巻103490頁-103490頁 2025年12月
-
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients. Tomohiro Koga,Remi Sumiyoshi,Toshimasa Shimizu,Naoki Hosogaya,Chizu Fukushima,Hiroshi Yamamoto,Hajime Yoshifuji,Shinji Higa,Atsushi Kawakami Cureus 17巻12号e98233頁- 2025年12月
-
Myeloperoxidase–anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis S Fukui,K Ichinose,H Ide,T Uchida,T Shimizu,M Umeda,R Sumiyoshi,T Koga,S-Y Kawashiri,N Iwamoto,T Origuchi,S Omura,D Nakagomi,Y Abe,M Wada,N Takizawa,A Nomura,Y Kukida,N Kondo,Y Yamano,H Takagi,K Endo,S Hirata,N Azuma,T Takeuchi,K Kamada,R Yanai,Y Matsuo,Y Shimojima,R Nishioka,R Okazaki,T Takata,M Moriyama,A Takatani,Y Miyawaki,T Shirai,H Dobashi,T Ito,I Matsumoto,T Takada,T Ito-Ihara,T Kida,N Yajima,T Kawaguchi,Y Kawahito,A Kawakami Scandinavian Journal of Rheumatology 1頁-9頁 2025年11月04日
-
Potential link between COVID-19 infection/vaccination and the onsets of TAFRO syndrome and idiopathic multicentric castleman disease. Masataka Umeda,Lamiaa Mohamed,Ayaka Umetsu,Mizuna Otsuka,Yushiro Endo,Toshimasa Shimizu,Shoichi Fukui,Remi Sumiyoshi,Tomohiro Koga,Atsushi Kawakami Immunology letters 278.107123-107123 2026/04
-
Visualizing malignant progression: in situ CD109-based spatial immunofluorescence assay delineates papillary to anaplastic thyroid carcinoma transformation within the tumor microenvironment. Tomoko Cohen,Keiji Suzuki,Katsuya Matsuda,Hirokazu Kurohama,Yuki Matsuoka,Mayu Ueda,Shinya Satoh,Hisakazu Shindo,Hiroyuki Yamashita,Atsushi Kawakami,Masahiro Nakashima Scientific reports 2026/02/26
-
Cytokine/chemokine profiles in rheumatoid arthritis patients who failed Boolean remission solely due to elevated patient global assessment. Shoichi Fukui,Tohru Michitsuji,Yushiro Endo,Ayako Nishino,Kaori Furukawa,Toshimasa Shimizu,Masataka Umeda,Remi Sumiyoshi,Tomohiro Koga,Naoki Iwamoto,Mami Tamai,Tomoki Origuchi,K A van Schie,Yukitaka Ueki,Nobutaka Eiraku,Tamami Yoshitama,Naoki Matsuoka,Takahisa Suzuki,Akitomo Okada,Hiroaki Hamada,Masahiro Ayano,Toshihiko Hidaka,Tomomi Tsuru,Tom W J Huizinga,René E M Toes,Atsushi Kawakami,Shin-Ya Kawashiri Rheumatology (Oxford, England) 65.2. 2026/02/04
-
A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoids. Remi Sumiyoshi,Tomohiro Koga,Osamu Kamisawa,Shimpei Morimoto,Naoki Hosogaya,Hiroshi Yamamoto,Makoto Hori,Yosuke Inaba,Yoko Hattori,Tamiki Hikake,Tomoya Kurokawa,Hideki Hanaoka,Shuzo Sato,Kiyoshi Migita,Noriyoshi Ogawa,Motomu Hashimoto,Atsushi Kawakami Drug discoveries & therapeutics 19.6.404-413 2026/01/07
-
Efficacy and safety of efgartigimod PH20 SC for Sjögren’s disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study) Yushiro Endo,Naoki Hosogaya,Yuri Fukushige,Sawana Narita,Julie Jacobs,William Reiss,Yuya Imai,Toshimasa Shimizu,Tomohiro Koga,Hiroshi Yamamoto,Tomoya Sakai,Yukinori Takagi,Misa Sumi,Atsushi Kawakami Frontiers in Medicine 12. 2026/01/02
-
Polychondritis and Arthritis in a Patient with Coexisting Alkaptonuria and Psoriasis Vulgaris. Kensei Shono,Eiko Kawakami,Serina Koto,Shoichi Fukui,Takashi Jubashi,Kanako Kojima,Toshimasa Shimizu,Hirofumi Koike,Nozomi Ueki,Atsushi Kawakami Internal medicine (Tokyo, Japan) 2025/12/11
-
Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer. Yomi Nakashima,Ichiro Horie,Haruka Arimori,Mayu Ueda,Shinpei Nishikido,Yuta Nakamura,Keita Nakaji,Tetsuro Niri,Ayaka Sako,Ai Haraguchi,Toshiyuki Ikeoka,Satoru Akazawa,Akie Moriuchi,Misa Imaizumi,Toshiro Usa,Atsushi Kawakami Endocrine journal 72.12.1327-1337 2025/12/01
-
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis Shoichi Fukui,Tohru Michitsuji,Yushiro Endo,Ayako Nishino,Kaori Furukawa,Toshimasa Shimizu,Masataka Umeda,Remi Sumiyoshi,Tomohiro Koga,Naoki Iwamoto,Mami Tamai,Tomoki Origuchi,K.A. van Schie,Yukitaka Ueki,Nobutaka Eiraku,Tamami Yoshitama,Naoki Matsuoka,Takahisa Suzuki,Akitomo Okada,Hiroaki Hamada,Masahiro Ayano,Toshihiko Hidaka,Tomomi Tsuru,Tom W.J. Huizinga,René E.M. Toes,Atsushi Kawakami,Shin-ya Kawashiri Journal of Autoimmunity 157.103490-103490 2025/12
-
A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients. Tomohiro Koga,Remi Sumiyoshi,Toshimasa Shimizu,Naoki Hosogaya,Chizu Fukushima,Hiroshi Yamamoto,Hajime Yoshifuji,Shinji Higa,Atsushi Kawakami Cureus 17.12.e98233- 2025/12
-
Myeloperoxidase–anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis S Fukui,K Ichinose,H Ide,T Uchida,T Shimizu,M Umeda,R Sumiyoshi,T Koga,S-Y Kawashiri,N Iwamoto,T Origuchi,S Omura,D Nakagomi,Y Abe,M Wada,N Takizawa,A Nomura,Y Kukida,N Kondo,Y Yamano,H Takagi,K Endo,S Hirata,N Azuma,T Takeuchi,K Kamada,R Yanai,Y Matsuo,Y Shimojima,R Nishioka,R Okazaki,T Takata,M Moriyama,A Takatani,Y Miyawaki,T Shirai,H Dobashi,T Ito,I Matsumoto,T Takada,T Ito-Ihara,T Kida,N Yajima,T Kawaguchi,Y Kawahito,A Kawakami Scandinavian Journal of Rheumatology 1-9 2025/11/04
|